Stay updated with breaking news from Myra vision inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ Myra Vision, a Shifamed portfolio company, announced today its Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System, a next-generation. ....
Myra Vision, Inc.: MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE SYSTEM, A NEXT GENERATION AQUEOUS SHUNT THERAPY FOR PATIENTS WITH MODERATE TO SEVERE GLAUCOMA finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
MYRA VISION ANNOUNCES SUCCESSFUL FIRST-IN-HUMAN USE OF ITS CALIBREYE™ SYSTEM, A NEXT GENERATION AQUEOUS SHUNT THERAPY FOR PATIENTS WITH MODERATE TO SEVERE GLAUCOMA streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series A Financings Company to accelerate development of the first-of-its-kind treatment for patients with moderate to severe glaucoma News provided by Share this article Share this article CAMPBELL, Calif., June 1, 2021 /PRNewswire/ Myra Vision, a Shifamed portfolio company, announced today the closing of its $17M Series A financings, which will be used to advance product development, scale infrastructure, and expand their team in order to support the development of the first of its kind glaucoma treatment device. The financings were led by The Capital Partnership (TCP), with participation from Cormorant Asset Management and Shifamed angel investors. In conjunction with the financing, the company has changed its name to Myra Vision, Inc. from Myra Medical, Inc. ....